日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study

阿米万单抗联合化疗治疗EGFR 20号外显子插入突变的非小细胞肺癌:PAPILLON III期研究中治疗交叉及其他终点的影响

Sanborn, Rachel E; Zhou, Caicun; Tang, Ke-Jing; Cho, Byoung Chul; Cheng, Susanna; Popat, Sanjay; Ono, Akira; Lu, Shun; Majem, Margarita; Aguilar, Andres; Del Rosario Garcia Campelo, Maria; Hayashi, Hidetoshi; Lee, Kang-Yun; Lee, Se-Hoon; Delmonte, Angelo; Alatorre-Alexander, Jorge; Richardson, Gary; Santos, Victor; Dooms, Christophe; Sabari, Joshua K; Shu, Catherine A; Girard, Nicolas; Mansfield, Aaron S; Park, Keunchil; Xia, Yichuan; Bhattacharya, Archan; Buyukkaramikli, Nasuh; Perualila, Nolen; Diels, Joris; Acharya, Sandip; Chandler, Conor; Proskorovsky, Irina; Dearden, Lindsay; Wortman-Vayn, Honeylet; Mahadevia, Parthiv J; Knoblauch, Roland E; Agrawal, Trishala; Baig, Mahadi; Felip, Enriqueta

Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCLC

LIBRETTO-431 研究的患者报告结局:RET 融合阳性非小细胞肺癌一线治疗中,塞帕替尼与帕博利珠单抗联合化疗的比较

Zhou, Caicun; Novello, Silvia; Garrido, Pilar; Dooms, Christophe; Alatorre-Alexander, Jorge; Reinmuth, Niels; Worthy, Gill; Cocks, Kim; Williams, Justin; Han, Hongmei; Uh, Minji K; Payakachat, Nalin; Gilligan, Adrienne M; Goto, Koichi

Mutation profile in liquid biopsy tested by next generation sequencing in Mexican patients with non-small cell lung carcinoma and its impact on survival

利用新一代测序技术检测墨西哥非小细胞肺癌患者液体活检中的突变谱及其对生存率的影响

Martínez-Herrera, José Fabián; Sánchez Domínguez, Gisela; Juárez-Vignon Whaley, Juan J; Carrasco-Cara Chards, Sonia; López Vrátný, Claudia; Guzmán Casta, Jordi; Riera Sala, Rodrigo F; Alatorre-Alexander, Jorge A; Seidman Sorsby, Alec; Cruz Zermeño, Mayte; Conde Flores, Emilio; Flores-Mariñelarena, Rodrigo R; Sánchez-Ríos, Carla P; Martínez-Barrera, Luis M; Gerson-Cwilich, Raquel; Santillán-Doherty, Patricio; Jiménez López, José C; López Hernández, William; Rodríguez-Cid, Jerónimo R

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

度伐利尤单抗联合或不联合曲美利尤单抗与化疗一线治疗转移性非小细胞肺癌:POSEIDON III期研究

Johnson, Melissa L; Cho, Byoung Chul; Luft, Alexander; Alatorre-Alexander, Jorge; Geater, Sarayut Lucien; Laktionov, Konstantin; Kim, Sang-We; Ursol, Grygorii; Hussein, Maen; Lim, Farah Louise; Yang, Cheng-Ta; Araujo, Luiz Henrique; Saito, Haruhiro; Reinmuth, Niels; Shi, Xiaojin; Poole, Lynne; Peters, Solange; Garon, Edward B; Mok, Tony

Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas

表柔比星、顺铂加异环磷酰胺与标准化疗方案治疗晚期/不可切除的原发性胸部肉瘤的疗效比较

Rodriguez-Cid, Jeronimo Rafael; Juarez-Vignon Whaley, Juan Jose; Sánchez-Domínguez, Gisela; Guzmán-Casta, Jordi; Carrasco-CaraChards, Sonia; Guzmán-Huesca, Jorge; Riera-Sala, Rodrigo; Sánchez-Ríos, Carla Paola; Cruz-Zermeño, Mayte; Seidman-Sorsby, Alec; de Jesús Rodríguez-Zea, Ivan; Alatorre-Alexander, Jorge Arturo; Martínez-Barrera, Luis Manuel; Santillán-Doherty, Patricio Javier; Godina-Flores, Aminadab; Imaz-Olguin, Victoria; Sosa-Sánchez, Ricardo; Green-Renner, Dan

High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial

在血液检测筛查试验中,高剂量阿来替尼用于RET融合阳性非小细胞肺癌

Dziadziuszko, Rafal; Peled, Nir; Mok, Tony; Peters, Solange; Aix, Santiago Ponce; Alatorre-Alexander, Jorge; Vicuna, Brian D; Maclennan, Margaret; Bhagawati-Prasad, Vijay; Shagan, Sarah M; Schleifman, Erica; Ruf, Thorsten; Mathisen, Michael S; Gadgeel, Shirish M

Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer

TAIL研究的最终结果:更新了阿特珠单抗在既往接受过治疗的晚期非小细胞肺癌患者群体中的长期疗效

Ardizzoni, Andrea; Azevedo, Sergio; Rubio-Viqueira, Belen; Rodriguez-Abreu, Delvys; Alatorre-Alexander, Jorge; Smit, Hans J M; Yu, Jinming; Syrigos, Konstantinos; Höglander, Elen; Kaul, Monika; Tolson, Jonathan; Hu, Youyou; Vollan, Hans Kristian; Newsom-Davis, Thomas

Survival prognostic factors in unresectable/advanced primary thoracic sarcomas

不可切除/晚期原发性胸部肉瘤的生存预后因素

Rodriguez-Cid, Jerónimo R; Juarez-Vignon Whaley, Juan J; Sánchez-Domínguez, Gisela; Guzmán-Casta, Jordi; Carrasco-CaraChards, Sonia; Alatorre-Alexander, Jorge A; Martínez-Barrera, Luis M; Sánchez-Rios, Carla P; Flores-Mariñelarena, Rodrigo R; Seidman-Sorsby, Alec; Cruz-Zermeño, Mayte; Rodríguez-Zea, Ivan J; Santillan-Doherty, Patricio J

Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

接受阿特珠单抗、卡铂和依托泊苷治疗的广泛期小细胞肺癌患者的总体生存期和PD-L1亚组分析更新(IMpower133)

Liu, Stephen V; Reck, Martin; Mansfield, Aaron S; Mok, Tony; Scherpereel, Arnaud; Reinmuth, Niels; Garassino, Marina Chiara; De Castro Carpeno, Javier; Califano, Raffaele; Nishio, Makoto; Orlandi, Francisco; Alatorre-Alexander, Jorge; Leal, Ticiana; Cheng, Ying; Lee, Jong-Seok; Lam, Sivuonthanh; McCleland, Mark; Deng, Yu; Phan, See; Horn, Leora

Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer

TAIL研究的主要结果:一项针对既往接受过治疗的晚期非小细胞肺癌患者的阿特珠单抗单药治疗的全球单臂安全性研究

Ardizzoni, Andrea; Azevedo, Sergio; Rubio-Viqueira, Belen; Rodríguez-Abreu, Delvys; Alatorre-Alexander, Jorge; Smit, Hans J M; Yu, Jinming; Syrigos, Konstantinos; Trunzer, Kerstin; Patel, Hina; Tolson, Jonathan; Cardona, Andres; Perez-Moreno, Pablo D; Newsom-Davis, Tom